Letter

Patients offered treatment for CHD need full information to make decision

BMJ 1998; 316 doi: 10.1136/bmj.316.7136.1021a (Published 28 March 1998)
Cite this as: BMJ 1998;316:1021.2

This article has a correction

Please see: Patients offered treatment for CHD need full information to make decision

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. P McCormack, Associate professor,
  2. Marc Levine, Associate professor,
  3. Robert E Rangno, Associate professor
  1. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
  2. Departments of Medicine, University of British Columbia

    EDITOR—Freemantle et al's editorial on the use of statins started a debate on treatment with cholesterol lowering drugs. 1 2 The subsequent editorial by Muldoon and Criqui,3 and many of the letters on this issue,2 continued to focus on identifying a level of absolute risk reduction at which treatment of patients at risk of coronary heart disease would be advised and, presumably, paid for by a healthcare service provider. In our opinion, most of the discussion failed to separate the issue of rational policy …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular